Dana Investment Advisors’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$175K Hold
23,600
0.01% 552
2025
Q4
$278K Hold
23,600
0.01% 523
2025
Q3
$182K Hold
23,600
0.01% 554
2025
Q2
$173K Hold
23,600
0.01% 534
2025
Q1
$224K Hold
23,600
0.01% 524
2024
Q4
$389K Hold
23,600
0.01% 478
2024
Q3
$348K Hold
23,600
0.01% 483
2024
Q2
$327K Hold
23,600
0.01% 472
2024
Q1
$371K Hold
23,600
0.01% 465
2023
Q4
$382K Hold
23,600
0.02% 353
2023
Q3
$290K Hold
23,600
0.01% 367
2023
Q2
$379K Hold
23,600
0.02% 345
2023
Q1
$411K Hold
23,600
0.02% 332
2022
Q4
$218K Sell
23,600
-17,360
-42% -$162K 0.01% 381
2022
Q3
$353K Sell
40,960
-460
-1% -$4.57K 0.02% 344
2022
Q2
$338K Buy
+41,420
New +$395K 0.02% 365

Other funds holding NEO

Dana Investment Advisors's NEO Position: Q1 2026 in Review

Dana Investment Advisors held its NeoGenomics (NEO) position steady in Q1 2026 at 23,600 shares worth $175K. The position accounts for 0.01% of the portfolio, ranked #552.

Dana Investment Advisors first reported a position in NEO in Q2 2022 and has held it in 16 quarters since. The position peaked at $411K in Q1 2023. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

  • Dana Investment Advisors held 23,600 shares of NeoGenomics worth $175K as of Q1 2026.
  • Dana Investment Advisors left its NeoGenomics share count unchanged in Q1 2026.
  • NeoGenomics made up 0.01% of Dana Investment Advisors's portfolio in Q1 2026, its #552 holding.
  • Dana Investment Advisors first reported a position in NeoGenomics in Q2 2022 and has held it in 16 quarters since.
  • Dana Investment Advisors's NeoGenomics position peaked at $411K in Q1 2023.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on Dana Investment Advisors's 13F filing for Q1 2026, filed 14 May 2026.